This study evaluates the impact of primary and secondary nonadherence to cholesterol medication on low-density lipoprotein levels, emergency department visits, and hospitalizations.
Jeffrey McCombs, PhD
Advertisement
Articles by Jeffrey McCombs, PhD
Advertisement
Latest Updated Articles
- Outcomes Associated With Primary and Secondary Nonadherence to Cholesterol Medications
Published: April 18th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
2
Pharmacy Policy Updates for October 2025
3
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
4
Expert: Tariff Increases May Pressure Pharmacy Margins and Supply Chains
5
